Evidence map›Paper›PMID 33901753›Full record

SynthesisDrug and alcohol dependence2021

The intersection of gender and drug use-related stigma: A mixed methods systematic review and synthesis of the literature.

S A Meyers, V A Earnshaw, B D'Ambrosio, N Courchesne, D Werb, L R Smith

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Drug and alcohol dependence, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 4 pooled it
18.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 4 syntheses or guidelines pooled it, 152 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Keeping PeopleInternational journal of social determinants of health and health services · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

S A MeyersDepartment of Psychology, San Diego State University, 5500 Campanile Drive, San Diego, CA, 92182, USA; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA.
V A EarnshawHuman Development and Family Sciences, University of Delaware, Newark, DE, 19716, USA.
B D'AmbrosioDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA; School of Social Work, College of Health and Human Services, San Diego State University, 5500 Campanile Drive, San Diego, CA, 92182, USA.
N CourchesneDepartment of Psychiatry, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA.
D WerbDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA; Centre for Urban Health Solutions, St. Michael's Hospital, 30 Bond Street, Toronto, ON, M5B 1W8, Canada.
L R SmithDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA. Electronic address: laramie@health.ucsd.edu.
San Diego State University · USUniversity of California San Diego · USSt. Michael's Hospital · CAUniversity of Delaware · US

Funding

A Technology-Delivered Peer-to-Peer Support ART Adherence Intervention for HIV+ AdultsR01DA039950 · NIDA · UNIVERSITY OF MINNESOTA · PI HORVATH, KEITH JOSEPH · 2015 to 2019
$3.3M
Preventing HIV by modifying the context for injecting initiationDP2DA040256 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WERB, DANIEL M · 2015 to 2015
$2.3M
HIV Treatment and Substance Use in LMIC Shaping MSMs Sociostructural ContextK01DA039767 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SMITH, LARAMIE RAE · 2015 to 2019
$906k
Understanding and Addressing Disclosure to Members of Social Networks among People Recovering from Substance Use DisordersK01DA042881 · NIDA · UNIVERSITY OF DELAWARE · PI EARNSHAW, VALERIE ANN · 2017 to 2020
$756k
Identifying Intersectional Stigma Intervention Targets for People Who Inject Drugs in a High-Risk International SettingR21TW011785 · FIC · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SMITH, LARAMIE RAE · 2020 to 2021
$418k
CIHRFIC NIH HHS R21 TW011785NIDA NIH HHS DP2 DA040256NIDA NIH HHS K01 DA039767NIDA NIH HHS K01 DA042881NIDA NIH HHS R01 DA039950
6 · The paper itself

Abstract

backgroundSubstance use-related stigma is a significant barrier to care among persons who use drugs (PWUD). Less is known regarding how intersectional identities, like gender, shape experiences of substance use-related stigma. We sought to answer the following question: Do men or women PWUD experience more drug use stigma?

methodsData were drawn from a systematic review of the global, peer-reviewed scientific literature on substance use-related stigma conducted through 2017 and guided by the Stigma and Substance Use Process Model and PRISMA guidelines. Articles were included in the present analysis if they either qualitatively illustrated themes related to the gendered nature of drug use-related stigma, or quantitatively tested the moderating effect of gender on drug use-related stigma.

resultsOf the 75 studies included, 40 (53 %) were quantitative and 35 (47 %) were qualitative. Of the quantitative articles, 22 (55 %) found no association between gender and drug use-related stigma, 4 (10 %) identified women who use drugs (WWUD) were more stigmatized, and 2 (5 %) determined men who use drugs (MWUD) were more stigmatized. In contrast, nearly all (34; 97 %) of the qualitative articles demonstrated WWUD experienced greater levels of drug use-related stigma.

conclusionThe quantitative literature is equivocal regarding the influence of gender on drug use-related stigma, but the qualitative literature more clearly demonstrates WWUD experience greater levels of stigma. The use of validated drug use-related stigma measures and the tailoring of stigma scales to WWUD are needed to understand the role of stigma in heightening the disproportionate harms experienced by WWUD.

Indexed as

Pharmaceutical PreparationsSubstance-Related DisordersFemaleGender IdentityHumansMaleSocial StigmaPharmaceutical PreparationsDrug useGenderIntersectionalityMixed methodsStigmaSystematic review

Identifiers

PMID33901753
PMCPMC8168566
OpenAlexW3155385798

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.